A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Investigational New Drugs
Falchook, Gerald S GS; Moulder, Stacy S; Naing, Aung A; Wheler, Jennifer J JJ; Hong, David S DS; Piha-Paul, Sarina A SA; Tsimberidou, Apostolia M AM; Fu, Siqing S; Zinner, Ralph R; Janku, Filip F; Jiang, Yunfang Y; Huang, Mei M; Parkhurst, Kristin L KL; Kurzrock, Razelle R